Clinical Trial Update: Zinc Supplementation Impact in Acute COVID-19 Clinical Outcomes [Phase 4]

View source ↗

Summary

Phase 4 trial investigating zinc supplementation and acute COVID-19 outcomes; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Zinc Deficiency

Drugs mentioned

• ZINC (Zinc chloride)

Snippet

Sponsor: Parc de Salut Mar | Conditions: Zinc Deficiency, Sars-CoV-2 Infection | Phase 4 | Status: COMPLETED